VectivBio, Reneo Pharma IPOs raise combined $221M for clinical trials April 9, 2021 Auto Bot Basel, BioPharma, biopharma nl, biotech IPO, Clinical Trials, Pharma, Switzerland 0 The public markets welcomed VectivBio and Reneo Pharmaceuticals, which priced their IPOs late Thursday. Both clinical-stage companies are developing drugs that address rare diseases.